Published in Cancer Res on July 01, 1995
Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol (1996) 5.62
Differential regulation of cell motility and invasion by FAK. J Cell Biol (2003) 3.15
Coupling of PAK-interacting exchange factor PIX to GIT1 promotes focal complex disassembly. Mol Cell Biol (2000) 2.92
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res (2006) 2.86
Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma. Cell Cycle (2010) 2.67
Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev (2004) 2.49
Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Mol Cell Biol (1997) 2.29
The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J (1998) 2.28
Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol (2001) 2.24
Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev (2010) 2.21
Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am J Pathol (2004) 2.12
An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling. J Cell Biol (2006) 2.08
Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. Cancer Res (2009) 2.04
FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion. J Cell Biol (2009) 1.97
Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer. Am J Pathol (2008) 1.82
Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Mol Cell Biol (2004) 1.79
Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. J Cell Biol (1999) 1.71
SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Mol Cell Biol (2004) 1.70
FIP200, a key signaling node to coordinately regulate various cellular processes. Cell Signal (2007) 1.64
Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance. Am J Pathol (2010) 1.63
Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells. Clin Cancer Res (2005) 1.63
The tyrosine kinase pyk2 promotes migration and invasion of glioma cells. Neoplasia (2005) 1.60
Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett (2009) 1.59
Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Eur J Nucl Med Mol Imaging (2005) 1.58
Cellular responses to substrate topography: role of myosin II and focal adhesion kinase. Biophys J (2006) 1.58
β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. J Clin Invest (2012) 1.56
Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase. J Cell Biol (1999) 1.52
Geldanamycin as a potential anti-cancer agent: its molecular target and biochemical activity. Invest New Drugs (1999) 1.46
Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell (2002) 1.46
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia (2011) 1.42
Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models. Cancer Biol Ther (2010) 1.41
Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron (2008) 1.37
Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. J Mammary Gland Biol Neoplasia (2011) 1.37
Focal adhesion kinase versus p53: apoptosis or survival? Sci Signal (2008) 1.36
MEK1 activation by PAK: a novel mechanism. Cell Signal (2007) 1.33
FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer (2003) 1.32
Dual targeting of EphA2 and FAK in ovarian carcinoma. Cancer Biol Ther (2009) 1.30
FAK engages multiple pathways to maintain survival of fibroblasts and epithelia: differential roles for paxillin and p130Cas. J Cell Sci (2009) 1.29
Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2. Mol Cell Biol (2001) 1.20
Focal adhesion kinase and p53 signal transduction pathways in cancer. Front Biosci (Landmark Ed) (2010) 1.20
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome. Breast Cancer Res (2005) 1.19
Focal adhesion kinase as a cancer therapy target. Anticancer Agents Med Chem (2010) 1.19
HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase. Mol Cancer Res (2010) 1.16
Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J Biol Chem (2010) 1.15
Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life (2010) 1.12
FAK is a critical regulator of neuroblastoma liver metastasis. Oncotarget (2012) 1.12
Specific induction of pp125 focal adhesion kinase in human breast cancer. Br J Cancer (2005) 1.11
Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics. Sci Signal (2013) 1.10
Normal morphogenesis of epithelial tissues and progression of epithelial tumors. Wiley Interdiscip Rev Syst Biol Med (2011) 1.10
In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation. Am J Pathol (2005) 1.10
Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study. J Korean Med Sci (2004) 1.09
FAK and p53 protein interactions. Anticancer Agents Med Chem (2011) 1.09
Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones. Cell Stress Chaperones (2001) 1.08
Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro. Am J Pathol (2001) 1.08
Molecular characterization of human tensin. Biochem J (2000) 1.04
Analysis of signaling protein kinases in human colon or colorectal carcinomas. Dig Dis Sci (1998) 1.04
Targeting Pyk2 for therapeutic intervention. Expert Opin Ther Targets (2010) 1.04
OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organization. Cell Microbiol (2007) 1.03
FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk. Int J Colorectal Dis (2012) 1.01
Visualizing and manipulating focal adhesion kinase regulation in live cells. J Biol Chem (2013) 1.01
Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging. Cell Adh Migr (2011) 1.00
The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis. BMC Cancer (2009) 0.99
Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase. Mol Carcinog (2009) 0.99
DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway. Oncogene (2010) 0.99
Targeting FAK in human cancer: from finding to first clinical trials. Front Biosci (Landmark Ed) (2014) 0.99
Laminin-332-beta1 integrin interactions negatively regulate invadopodia. J Cell Physiol (2010) 0.98
CrkII regulates focal adhesion kinase activation by making a complex with Crk-associated substrate, p130Cas. Proc Natl Acad Sci U S A (2004) 0.97
Endothelial FAK as a therapeutic target in disease. Microvasc Res (2011) 0.96
Disruption of focal adhesion kinase and p53 interaction with small molecule compound R2 reactivated p53 and blocked tumor growth. BMC Cancer (2013) 0.96
Activated Src increases adhesion, survival and alpha2-integrin expression in human breast cancer cells. Biochem J (2004) 0.96
Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling. Biochem J (2006) 0.96
Gene array and fluorescence in situ hybridization biomarkers of activity of saracatinib (AZD0530), a Src inhibitor, in a preclinical model of colorectal cancer. Clin Cancer Res (2010) 0.96
Syndecan-2 regulates the migratory potential of melanoma cells. J Biol Chem (2009) 0.95
Down-regulation of Gli transcription factor leads to the inhibition of migration and invasion of ovarian cancer cells via integrin β4-mediated FAK signaling. PLoS One (2014) 0.94
Differential FAK phosphorylation at Ser-910, Ser-843 and Tyr-397 induced by angiotensin II, LPA and EGF in intestinal epithelial cells. Cell Signal (2006) 0.94
FAK dimerization controls its kinase-dependent functions at focal adhesions. EMBO J (2014) 0.93
Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells. Clin Exp Metastasis (2007) 0.93
Targeting of the protein interaction site between FAK and IGF-1R. Biochem Biophys Res Commun (2009) 0.92
CFTR Cl- channel functional regulation by phosphorylation of focal adhesion kinase at tyrosine 407 in osmosensitive ion transporting mitochondria rich cells of euryhaline killifish. J Exp Biol (2009) 0.92
S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase. Sci Rep (2015) 0.91
Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell lines. Diagn Pathol (2010) 0.90
Effect of CD44 binding peptide conjugated to an engineered inert matrix on maintenance of breast cancer stem cells and tumorsphere formation. PLoS One (2013) 0.90
Emerging roles of focal adhesion kinase in cancer. Biomed Res Int (2015) 0.90
Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression. Crit Rev Eukaryot Gene Expr (2013) 0.90
Expression and prognostic significance of focal adhesion kinase in hepatocellular carcinoma. J Cancer Res Clin Oncol (2010) 0.90
Ethanol enhances the interaction of breast cancer cells over-expressing ErbB2 with fibronectin. Alcohol Clin Exp Res (2010) 0.89
Mesenchymal migration as a therapeutic target in glioblastoma. J Oncol (2010) 0.89
Focal adhesion kinase functions as an akt downstream target in migration of colorectal cancer cells. Transl Oncol (2009) 0.89
Systems microscopy approaches to understand cancer cell migration and metastasis. Cell Mol Life Sci (2010) 0.89
FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells. Oncotarget (2015) 0.88
Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1. World J Gastroenterol (2005) 0.86
Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance. World J Gastroenterol (2014) 0.86
Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro. Dig Dis Sci (2008) 0.86
Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells. Biochem J (1997) 0.85
Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells. Clin Exp Metastasis (2011) 0.85
Role of FRNK tyrosine phosphorylation in vascular smooth muscle spreading and migration. Cardiovasc Res (2009) 0.85
Receptor-interacting protein shuttles between cell death and survival signaling pathways. Mol Biol Cell (2009) 0.85
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (1996) 11.02
DMC1: a meiosis-specific yeast homolog of E. coli recA required for recombination, synaptonemal complex formation, and cell cycle progression. Cell (1992) 10.48
High-fidelity mRNA amplification for gene profiling. Nat Biotechnol (2000) 6.97
Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood (1998) 6.81
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med (2001) 5.54
Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity (1999) 5.34
Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 4.59
Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science (1998) 4.55
Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat Med (2000) 4.55
Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 4.24
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med (1994) 3.89
High-level semi-synthetic production of the potent antimalarial artemisinin. Nature (2013) 3.80
axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol (1991) 3.57
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer. J Natl Cancer Inst (1998) 3.56
Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature (1994) 3.36
Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci (2000) 3.14
Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res (2000) 3.03
Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99
Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet (2002) 2.90
The TGF beta receptor activation process: an inhibitor- to substrate-binding switch. Mol Cell (2001) 2.87
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. Diabetologia (2006) 2.82
Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1. Mol Cell Biol (2000) 2.80
Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem (1996) 2.78
Paternal population history of East Asia: sources, patterns, and microevolutionary processes. Am J Hum Genet (2001) 2.71
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A (1997) 2.63
Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res (2000) 2.62
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol (2005) 2.54
Comparison of the prevalence of knee osteoarthritis between the elderly Chinese population in Beijing and whites in the United States: The Beijing Osteoarthritis Study. Arthritis Rheum (2001) 2.45
The skeletal muscle calcium release channel: coupled O2 sensor and NO signaling functions. Cell (2000) 2.41
The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat (1995) 2.31
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
A panoramic code for sound location by cortical neurons. Science (1994) 2.30
Synaptonemal complex (SC) component Zip1 plays a role in meiotic recombination independent of SC polymerization along the chromosomes. Proc Natl Acad Sci U S A (1996) 2.29
A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ (2010) 2.25
Casein kinase iepsilon in the wnt pathway: regulation of beta-catenin function. Proc Natl Acad Sci U S A (1999) 2.25
Lactation is associated with greater maternal bone size and bone strength later in life. Osteoporos Int (2011) 2.19
The ryanodine receptor-Ca2+ release channel complex of skeletal muscle sarcoplasmic reticulum. Evidence for a cooperatively coupled, negatively charged homotetramer. J Biol Chem (1989) 2.18
Calmodulin activation and inhibition of skeletal muscle Ca2+ release channel (ryanodine receptor). Biophys J (1995) 2.18
The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways. J Biol Chem (2000) 2.17
PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci U S A (2000) 2.17
Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res (2001) 2.11
Differential use of CREB binding protein-coactivator complexes. Science (1998) 2.10
Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ (1996) 2.09
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma. Ann Oncol (2011) 2.05
Role for phospholipase D in receptor-mediated endocytosis. Mol Cell Biol (2001) 1.96
Expression of focal adhesion kinase gene and invasive cancer. Lancet (1993) 1.93
Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice. J Thromb Haemost (2005) 1.92
DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J Clin Invest (2001) 1.89
Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol (1996) 1.87
S region transcription per se promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO J (1994) 1.84
Glass transition in biomolecules and the liquid-liquid critical point of water. Phys Rev Lett (2006) 1.82
Peripheral nervous system defects in erbB2 mutants following genetic rescue of heart development. Genes Dev (1999) 1.82
Activation of the skeletal muscle calcium release channel by a cytoplasmic loop of the dihydropyridine receptor. J Biol Chem (1994) 1.80
Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol (2001) 1.74
Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer (1999) 1.74
Nucleotide sequence, function, activation, and evolution of the cryptic asc operon of Escherichia coli K12. Mol Biol Evol (1992) 1.70
Cloning and expression of phosphatidylcholine-hydrolyzing phospholipase D from Ricinus communis L. J Biol Chem (1994) 1.69
Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength. Immunity (2001) 1.68
Replication fork assembly at recombination intermediates is required for bacterial growth. Proc Natl Acad Sci U S A (1999) 1.68
Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. J Biol Chem (1994) 1.67
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther (2001) 1.65
Predicting the onset of net carbon uptake by deciduous forests with soil temperature and climate data: a synthesis of FLUXNET data. Int J Biometeorol (2005) 1.64
Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase. J Biol Chem (1995) 1.64
Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology (1993) 1.64
Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J Exp Med (2001) 1.62
Evidence for a role of the lumenal M3-M4 loop in skeletal muscle Ca(2+) release channel (ryanodine receptor) activity and conductance. Biophys J (2000) 1.61
Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer. J Clin Endocrinol Metab (2006) 1.60
Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI. Nat Immunol (2000) 1.60
Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor). J Biol Chem (2001) 1.58
Generation of retroviral vector for clinical studies using transient transfection. Hum Gene Ther (1999) 1.57
Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc Natl Acad Sci U S A (1994) 1.56
Signal transduction by cell adhesion receptors. Biochim Biophys Acta (1995) 1.55
7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J Clin Invest (2001) 1.55
Imperatoxin A induces subconductance states in Ca2+ release channels (ryanodine receptors) of cardiac and skeletal muscle. J Gen Physiol (1998) 1.54
The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage. J Biol Chem (1995) 1.52
Biologic and biochemical analyses of p16(INK4a) mutations from primary tumors. J Natl Cancer Inst (1999) 1.52
Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase. Mol Cell Biol (1996) 1.50
Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro. Protein Expr Purif (1999) 1.50
Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes Dev (2001) 1.49
Pathogenesis of osteoarthritis-like changes in the joints of mice deficient in type IX collagen. Arthritis Rheum (2006) 1.49
Crossover and noncrossover recombination during meiosis: timing and pathway relationships. Proc Natl Acad Sci U S A (1995) 1.49
BRCA1-associated growth arrest is RB-dependent. Proc Natl Acad Sci U S A (1999) 1.47
Amphibian ryanodine receptor isoforms are related to those of mammalian skeletal or cardiac muscle. Am J Physiol (1992) 1.47
Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product. J Virol (1992) 1.46
Agricultural risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma. Epidemiology (2001) 1.44
The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth Differ (1998) 1.44
A simplified local control model of calcium-induced calcium release in cardiac ventricular myocytes. Biophys J (2004) 1.44
Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia. Am J Physiol Heart Circ Physiol (2001) 1.44
GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J Biol Chem (1998) 1.44
Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye (Lond) (2008) 1.43